Recruiting Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma NCT07086469 Conditions Carcinoma, Carcinoma, Squamous Cell, Chemoradiotherapy, +16 more Locations Sun yat-sen University Cancer Center — Guangzhou, Guangdong, China View Trial Details
Recruiting Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy NCT07088354 Conditions Carcinoma, Carcinoma, Squamous Cell, Deep Learning, +15 more Locations Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology — Wuhan, Hubei, China View Trial Details
Not Yet Recruiting Efficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients With Stable Disease After Two Treatment Courses: A Single-Arm Exploratory Study NCT06722495 Conditions LA HNSCC, Neoadjuvant Immunochemotherapy, SBRT Locations Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University — Guangzhou, Guangdong, China View Trial Details
